PSYCHOLOGICAL FACTOR AFFECTING ENGLISH SPEAKING PERFORMANCE FOR THE ENGLISH LEARNERS IN INDONESIA

In every learning situation or environment, human psychology plays a significant role. English speaking is a language skill that is highly affected by human psychology. The aim of this study was to find out the psychological factor that affects most of the Indonesians‘ English speaking performance in order to propose some solutions to overcome the problem. This study used a descriptive qualitative research methodology to collect the data. The Indonesians who learnt English for their undergraduate program had been the population of this study. The researcher also purposefully selected some Applied Linguistics master program students in English education at YSU to act as research samples. So, after having analyzed the collected data from those participants by using some observations tools to find out the barriers students face in English speaking performance, it was clear that most of those students‘s desire is to speak English as well as they speak their first language. Unfortunately, most of them showed increased levels of anxieties. Although most of the students think that they have a good level of vocabulary or grammar, they also keep on feeling insecure while speaking. Most of the barriers were: being worried of making mistakes, feeling shy, and feeling frustrated while performing in English speaking. Finally, the researcher has proposed some solutions that are expected to be significant remedies to overcome the problems mentioned above. Keywords: English as Foreign Language in Indonesia, English Speaking difficulties, and Psychological Factor

Study of the effectiveness of training Malian social and health agents in female genital cutting issues and in educating their clients

This report documents findings of a study to assess the education and training of social and healthcare workers in Mali regarding female genital cutting (FGC). After two decades of campaigning against FGC in Mali, the results are not satisfactory when compared to the levels of human and financial investment. The Mali Division of Family and Community Health, with technical support from the Population Council, conducted this research to highlight certain issues related to the practice of FGC in Mali, in particular health consequences and the role health personnel can play in eradicating the practice. The continued prevalence of FGC among dominant ethnic groups and the risk of its spreading to minority ethnic groups which do not traditionally circumcise females justify the continuation and extension of the campaign. Future research avenues, such as ways to improve IEC tools and training in health facilities, and improving outreach programs particularly among youths, should be explored

An Analysis of the Phonemic Errors in the English Speaking Practices Performed by the Undergraduate Students of English Education Department, Yogyakarta State University in the Academic Year of 2014-2015

This research aims at describing: (1) the phonemic errors in the English speaking practices performed by the second semester undergraduate students of the English Education Department, Yogyakarta State University (YSU) in the academic year of 2014-2015; (2) and the motivating factors of the phonemic errors occurring in the students’ English speaking performance. A descriptive qualitative research method was used for this research. The participants of this research were 36 students. The data of this research were gathered by using three different techniques of data collection consisting of observations, questionnaires, and open-ended interviews. The data were collected first by conducting some observations, then, by distributing questionnaires to the research sample, and finally, by conducting open-ended interviews with 20 students from the research sample. The data gathered from the observations, questionnaires, and interviews were then analyzed using an interactive analysis technique developed by Miles and Huberman (1994). The results of the research show that 21 English phonemes were produced with deviations. Those deviations consist of 27 cases of phoneme substitution, six cases of phoneme deletion, and three cases of phoneme addition. There are some motivating factors for those phonemic errors’ occurrence. First, the English sound system is different from the Bahasa Indonesia sound system. Second, the respondents’ first language sound system (Bahasa Indonesia) affects their way of pronouncing some English sounds. Third, the students work with English phonetic transcriptions in a different class from their speaking class, they do not practice them in their speaking class

Safety and immunogenicity of quadrivalent meningococcal polysaccharide vaccine (MPV ACYW135) compared with quadrivalent meningococcal conjugate vaccine (Menactra®) in Malian children

Affordable, polyvalent meningococcal vaccines are needed for use in emergency reactive immunization campaigns. A phase IV randomized, observer-blind, controlled study compared the safety and immunogenicity of a quadrivalent meningococcal polysaccharide vaccine (MPV-4, MPV ACYW135) and quadrivalent meningococcal ACWY conjugate vaccine (MCV-4, Menactra®). Healthy, 2- to 10-year-old children in Bamako, Mali, were randomized 1:1 to receive one dose of MPV-4 or MCV-4. Safety outcomes were evaluated for 6 months post-immunization. Immunogenicity for all serogroups was assessed for non-inferiority between MPV-4 and MCV-4 30 days post immunization by serum bactericidal antibody assay using baby rabbit complement (rSBA). From December 2020 to July 2021, 260 healthy subjects were consented and randomized. At Day 30 post-immunization, the proportions of subjects with rSBA titers ≥ 128 for all serogroups in the MPV-4 group were non-inferior to those in MCV-4 group. The proportions of subjects with rSBA ≥ 4-fold increase and rSBA titers ≥ 8 for all serogroups were similar among vaccine groups (P > .05). Geometric Mean Titers and Geometric Mean Fold Increases for all serogroups in both vaccine groups were similar (P > .05). Few local and systemic post-immunization reactions of similar severity and duration were observed within 7 days and were similar in both groups (P > .05). All resolved without sequelae. Unsolicited adverse events were similar in both groups regarding relationship to study vaccine, severity and duration. No serious adverse events were reported during the study period. MPV ACYW135 showed a non-inferior immunogenicity profile and a comparable reactogenicity profile to MCV-4 in Malian children aged 2–10 years. Clinical Trial Registration: NCT04450498

Meningococcal ACWYX Conjugate Vaccine in 2-to-29-Year-Olds in Mali and Gambia.

BACKGROUND: An effective, affordable, multivalent meningococcal conjugate vaccine is needed to prevent epidemic meningitis in the African meningitis belt. Data on the safety and immunogenicity of NmCV-5, a pentavalent vaccine targeting the A, C, W, Y, and X serogroups, have been limited. METHODS: We conducted a phase 3, noninferiority trial involving healthy 2-to-29-year-olds in Mali and Gambia. Participants were randomly assigned in a 2:1 ratio to receive a single intramuscular dose of NmCV-5 or the quadrivalent vaccine MenACWY-D. Immunogenicity was assessed at day 28. The noninferiority of NmCV-5 to MenACWY-D was assessed on the basis of the difference in the percentage of participants with a seroresponse (defined as prespecified changes in titer; margin, lower limit of the 96% confidence interval [CI] above -10 percentage points) or geometric mean titer (GMT) ratios (margin, lower limit of the 98.98% CI >0.5). Serogroup X responses in the NmCV-5 group were compared with the lowest response among the MenACWY-D serogroups. Safety was also assessed. RESULTS: A total of 1800 participants received NmCV-5 or MenACWY-D. In the NmCV-5 group, the percentage of participants with a seroresponse ranged from 70.5% (95% CI, 67.8 to 73.2) for serogroup A to 98.5% (95% CI, 97.6 to 99.2) for serogroup W; the percentage with a serogroup X response was 97.2% (95% CI, 96.0 to 98.1). The overall difference between the two vaccines in seroresponse for the four shared serogroups ranged from 1.2 percentage points (96% CI, -0.3 to 3.1) for serogroup W to 20.5 percentage points (96% CI, 15.4 to 25.6) for serogroup A. The overall GMT ratios for the four shared serogroups ranged from 1.7 (98.98% CI, 1.5 to 1.9) for serogroup A to 2.8 (98.98% CI, 2.3 to 3.5) for serogroup C. The serogroup X component of the NmCV-5 vaccine generated seroresponses and GMTs that met the prespecified noninferiority criteria. The incidence of systemic adverse events was similar in the two groups (11.1% in the NmCV-5 group and 9.2% in the MenACWY-D group). CONCLUSIONS: For all four serotypes in common with the MenACWY-D vaccine, the NmCV-5 vaccine elicited immune responses that were noninferior to those elicited by the MenACWY-D vaccine. NmCV-5 also elicited immune responses to serogroup X. No safety concerns were evident. (Funded by the U.K. Foreign, Commonwealth, and Development Office and others; ClinicalTrials.gov number, NCT03964012.)

Quantifying the Cost of <i>Shigella</i> Diarrhea in the Enterics for Global Health (EFGH) <i>Shigella</i> Surveillance Study.

BackgroundComparative costs of public health interventions provide valuable data for decision making. However, the availability of comprehensive and context-specific costs is often limited. The Enterics for Global Health (EFGH) Shigella surveillance study-a facility-based diarrhea surveillance study across 7 countries-aims to generate evidence on health system and household costs associated with medically attended Shigella diarrhea in children.MethodsEFGH working groups comprising representatives from each country (Bangladesh, Kenya, Malawi, Mali, Pakistan, Peru, and The Gambia) developed the study methods. Over a 24-month surveillance period, facility-based surveys will collect data on resource use for the medical treatment of an estimated 9800 children aged 6-35 months with diarrhea. Through these surveys, we will describe and quantify medical resources used in the treatment of diarrhea (eg, medication, supplies, and provider salaries), nonmedical resources (eg, travel costs to the facility), and the amount of caregiver time lost from work to care for their sick child. To assign costs to each identified resource, we will use a combination of caregiver interviews, national medical price lists, and databases from the World Health Organization and the International Labor Organization. Our primary outcome will be the estimated cost per inpatient and outpatient episode of medically attended Shigella diarrhea treatment across countries, levels of care, and illness severity. We will conduct sensitivity and scenario analysis to determine how unit costs vary across scenarios.ConclusionsResults from this study will contribute to the existing body of literature on diarrhea costing and inform future policy decisions related to investments in preventive strategies for Shigella

Diarrhea Case Surveillance in the Enterics for Global Health <i>Shigella</i> Surveillance Study: Epidemiologic Methods.

BackgroundShigella is a leading cause of acute watery diarrhea, dysentery, and diarrhea-attributed linear growth faltering, a precursor to stunting and lifelong morbidity. Several promising Shigella vaccines are in development and field efficacy trials will require a consortium of potential vaccine trial sites with up-to-date Shigella diarrhea incidence data.MethodsThe Enterics for Global Health (EFGH) Shigella surveillance study will employ facility-based enrollment of diarrhea cases aged 6-35 months with 3 months of follow-up to establish incidence rates and document clinical, anthropometric, and financial consequences of Shigella diarrhea at 7 country sites (Mali, Kenya, The Gambia, Malawi, Bangladesh, Pakistan, and Peru). Over a 24-month period between 2022 and 2024, the EFGH study aims to enroll 9800 children (1400 per country site) between 6 and 35 months of age who present to local health facilities with diarrhea. Shigella species (spp.) will be identified and serotyped from rectal swabs by conventional microbiologic methods and quantitative polymerase chain reaction. Shigella spp. isolates will undergo serotyping and antimicrobial susceptibility testing. Incorporating population and healthcare utilization estimates from contemporaneous household sampling in the catchment areas of enrollment facilities, we will estimate Shigella diarrhea incidence rates.ConclusionsThis multicountry surveillance network will provide key incidence data needed to design Shigella vaccine trials and strengthen readiness for potential trial implementation. Data collected in EFGH will inform policy makers about the relative importance of this vaccine-preventable disease, accelerating the time to vaccine availability and uptake among children in high-burden settings